HomeOpen Access NewsHealth & Social Care

Health & Social Care

Plastic-digesting superbug found in hospitals poses massive danger

A dangerous hospital superbug, Pseudomonas aeruginosa, can now digest medical plastic like sutures and implants, microbiologists reveal. This alarming ability allows the pathogen to survive longer and form tougher antibiotic-resistant biofilms, posing a significant new threat to patient safety in healthcare settings.

Enhancing patients and caregivers lives through digital health platforms

Digital health platforms offer vast potential for enhancing the lives of PD patients and caregivers. A study in the Journal of Nutrition Education and Behavior emphasises their role in improving healthcare services.

Investing in health will lead to a better and wealthier future

Dr Josep Figueras, Dr Matthias Wismar from European Observatory on Health Systems and Policies, with Dr Natasha Azzopardi Muscat from WHO/Europe, argue that investing in health will lead to a better and wealthier future.

Chinese tropical plant shows antiobesity potential

A research team led by Professor Akiko Kojima from Osaka Metropolitan University uncovers the antiobesity potential of the tropical plant Mallotus furetianus.

Machine learning identifies physical signs of stroke

Researchers presented a groundbreaking app at the Society of NeuroInterventional Surgery's 20th Annual Meeting, using machine learning to detect physical signs of stroke.

What does obesity have to do with the rise in malnutrition in the UK

We tend to associate malnutrition with being underweight due to hunger and starvation. In fact, although this is indeed the case, obesity is also a major cause of malnutrition in the UK.

Opportunities and challenges in blood collection and transfusion medicine

Kate Fry, CEO of America’s Blood Centers, discusses the essential role of blood products and transfusion medicine in the U.S. and the efforts to ensure blood’s safety and availability.

Can poor oral hygiene lead to dementia?

Dr Deborah Lee from Dr Fox Pharmacy shares evidence on the link between poor mouth care and dementia risk, and the steps needed to promote better oral hygiene.

Does a high-fibre diet reduce the risk of cancer?

Research is now showing that cancer risk can be reduced by increasing the amount of fibre in the diet, is this true?

The eight habits researchers recommend to lengthen life expectancy

Surveying over 700,000 U.S veterans has revealed that adopting eight lifestyle habits by middle age can extend life expectancy by years, if not decades.

Rethinking approaches to care for older adults

Older adults are among the most frequent users of emergency care; Open Access Government explains why this is and the suggested measures to improve and diversify care delivery and support the recovery of health and social care systems.

Detect & prevent falls in care homes with RoomMate

Sven Seljom, UK Country Manager at Sensio, walks us through a revolutionary safety sensor, RoomMate, that detects and prevents falls in care homes.

Healthcare AI Caution: Addressing ethnic health inequalities

Healthcare AI models must proceed cautiously to avoid exacerbating health inequalities for ethnic minorities, warn scientists.

A new era of pathogen surveillance using genomic sequencing

We spoke to Dr Joanne Hackett, Former Chief Commercial Officer of Genomics England and Regional Board Member of Movement Health 2030, about how genomic...

Are you drinking enough water? Ten reasons to drink more water

Only 53% of UK adults are drinking enough water, according to Water Logic. Yet being just 1% dehydrated has serious implications for our health. Here are 10 reasons to drink more water along with some tips and tricks.

Building a better, safer and more accountable sport system in Canada

The Honourable Pascale St-Onge, Canada’s Minister responsible for Sport, shares her vision for a safe and accountable sport system in which Canadian athletes from all walks of life can thrive.

Experimental Alzheimer’s drug slows progression of early disease

An experimental Alzheimer's drug called donanemab, developed by Eli Lilly, has demonstrated a slowdown in progression of disease at early stages, according to trial data.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders